InflaRx NV (IFRX) is now in the Overvalued zone, suggesting that its current forward PS ratio of 1335.30 is considered Overvalued compared with the five-year average of -2.31. The fair price of InflaRx NV (IFRX) is between 0.19 to 0.82 according to relative valuation method. Compared to the current price of 0.92 USD , InflaRx NV By Overvalued By 12.2%.

Relative Value

Fair Zone

0.19-0.82

Current Price：0.92

12.2%

Overvalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is InflaRx NV (IFRX) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

InflaRx NV (IFRX) has a current Price-to-Book (P/B) ratio of 1.39. Compared to its 3-year average P/B ratio of 1.30, the current P/B ratio is approximately 7.00% higher. Relative to its 5-year average P/B ratio of 1.18, the current P/B ratio is about 17.88% higher. InflaRx NV (IFRX) has a Forward Free Cash Flow (FCF) yield of approximately -67.64%. Compared to its 3-year average FCF yield of -46.58%, the current FCF yield is approximately 45.22% lower. Relative to its 5-year average FCF yield of -43.66%, the current FCF yield is about 54.93% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for IFRX competitors is 225.27, providing a benchmark for relative valuation. InflaRx NV Corp (IFRX.O) exhibits a P/S ratio of 1335.30, which is 492.76% above the industry average. Given its robust revenue growth of -80.75%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of IFRX increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of IFRX in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is IFRX currently overvalued or undervalued?

What is InflaRx NV (IFRX) fair value?

IFRX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of InflaRx NV (IFRX) is between 0.19 to 0.82 according to relative valuation method.

How does IFRX's valuation metrics compare to the industry average?

The average P/S ratio for IFRX's competitors is 225.27, providing a benchmark for relative valuation. InflaRx NV Corp (IFRX) exhibits a P/S ratio of 1335.30, which is 492.76% above the industry average. Given its robust revenue growth of -80.75%, this premium appears unsustainable.

What is the current P/B ratio for InflaRx NV (IFRX) as of Mar 03 2026?

As of Mar 03 2026, InflaRx NV (IFRX) has a P/B ratio of 1.39. This indicates that the market values IFRX at 1.39 times its book value.

What is the current FCF Yield for InflaRx NV (IFRX) as of Mar 03 2026?

As of Mar 03 2026, InflaRx NV (IFRX) has a FCF Yield of -67.64%. This means that for every dollar of InflaRx NV's market capitalization, the company generates -67.64 cents in free cash flow.

What is the current Forward P/E ratio for InflaRx NV (IFRX) as of Mar 03 2026?

As of Mar 03 2026, InflaRx NV (IFRX) has a Forward P/E ratio of -1.80. This means the market is willing to pay $-1.80 for every dollar of InflaRx NV's expected earnings over the next 12 months.

What is the current Forward P/S ratio for InflaRx NV (IFRX) as of Mar 03 2026?

As of Mar 03 2026, InflaRx NV (IFRX) has a Forward P/S ratio of 1335.30. This means the market is valuing IFRX at $1335.30 for every dollar of expected revenue over the next 12 months.

IFRX Valuation